Medibio Limited (ASX: MEB)
Medibio Limited (ASX: MEB) is a digital health company that has pioneered the use of objective biometrics to assist in the diagnosis and treatment of depression and other mental health disorders. www.medibio.com.au
Medibio completes first ilumen wellbeing pilot with Compass Group
Health technology company MediBio (ASX: MEB) has completed the first of four planned pilot programs using its ilumen corporate health and wellbe...
Medibio partners with Australian wellness company to develop workplace mental well-being solution
Health technology company Medibio Limited (ASX: MEB) has announced it will join forces with digital corporate wellness developer WellteQ to prov...
Medibio signs two pilot contracts with Compass Group for its ilumen product
Health technology company Medibio (ASX: MEB) has taken an assertive step towards commercialising its corporate health product called ‘ilumen’ af...
Medibio welcomes industry stars Rio Tinto and AFL as clients
Mental health technology company Medibio (ASX: MEB) has announced further commercial contracts with industry-leading names such as Rio Tinto (AS...
Medibio strikes a deal with Australia’s leading Catholic healthcare provider
Dual-listed mental health technology company Medibio (ASX: MEB) has struck a potentially lucrative commercial deal with St John of God Health Ca...
Medibio clinches CE Marking accreditation for mental health platform
Mental-health technology company Medibio (ASX: MEB) has received European CE Marking certification for its stress-phenotype and sleep-assessing ...
Medibio bags second clinical trial agreement with world-leading Mayo Clinic
Digital mental health company Medibio Limited (ASX: MEB) has inked a five-year clinical trial agreement with the United States’ top hospital: Ma...